Trial site
Florida Cancer Specialists
- 42running trials
- 17closed trials
The trials here
What the 60 trials at this site are about, from their registry records.
- Conditions
- Lung cancer26 trials
- Colorectal cancer17 trials
- Ovarian cancer15 trials
- Prostate cancer14 trials
- Pancreatic cancer11 trials
- Endometrial cancer10 trials
- Triple-negative breast cancer10 trials
- Gastric and oesophageal cancer8 trials
- Head and neck cancer8 trials
- Chronic lymphocytic leukaemia6 trials
- Metastatic breast cancer6 trials
- Bladder cancer5 trials
- and 17 more
- Phase
- Phase 128 trials
- Phase 1/217 trials
- Phase 37 trials
- Phase 25 trials
- Phase 43 trials
- Status
- Recruiting32 trials
- Completed12 trials
- Active, not recruiting10 trials
- Terminated5 trials
- Suspended1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Pfizer7 trials
- Eli Lilly and Company4 trials
- Incyte Corporation3 trials
- Compugen Ltd2 trials
- and 31 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Recruiting
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Active, not recruiting
Recruiting
Recruiting
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Recruiting
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Active, not recruiting
Recruiting
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Active, not recruiting
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Recruiting
Recruiting
Recruiting
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Recruiting
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Active, not recruiting
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Recruiting
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Active, not recruiting
Active, not recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Recruiting
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Active, not recruiting
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Active, not recruiting
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer13 recruiting
- Prostate cancer9 recruiting
- Colorectal cancer8 recruiting
- Chronic lymphocytic leukaemia5 recruiting
- Gastric and oesophageal cancer5 recruiting
- Ovarian cancer5 recruiting
- Pancreatic cancer5 recruiting
- Endometrial cancer4 recruiting
- Metastatic breast cancer4 recruiting
- Head and neck cancer3 recruiting
- Triple-negative breast cancer3 recruiting
- Cervical cancer2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Follicular lymphoma2 recruiting
- Kidney cancer2 recruiting
- Mantle cell lymphoma2 recruiting
- Bladder cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Sarcoma1 recruiting
Closed trials
Terminated
Terminated
Completed
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Completed
Completed
Completed
A Study of PRT2527 in Participants With Advanced Solid Tumors
Terminated
Completed
Terminated
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
Terminated
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Completed
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Completed
Completed
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
Completed
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Completed
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026